A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta

Published: 27 February 2023| Version 1 | DOI: 10.17632/p4c823jzxz.1
Contributors:
Brandon Carter, Pinghan Huang, Ge Liu, Yuejin Liang, Paulo J. C. Lin, Bi-Hung Peng, Lindsay McKay, Alexander Dimitrakakis, Jason Hsu, Vivian Tat, Panatda Saenkham-Huntsinger, Jinjin Chen, Clarety Kaseke, Gaurav D. Gaiha, Qiaobing Xu, Anthony Griffiths, Ying Tam, Chien-Te K. Tseng, David Gifford

Description

This repository contains original data collected for the paper: A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta Brandon Carter, Pinghan Huang, Ge Liu, Yuejin Liang, Paulo J. C. Lin, Bi-Hung Peng, Lindsay G. A. McKay, Alexander Dimitrakakis, Jason Hsu, Vivian Tat, Panatda Saenkham-Huntsinger, Jinjin Chen, Clarety Kaseke, Gaurav D. Gaiha, Qiaobing Xu, Anthony Griffiths, Ying K. Tam, Chien-Te K. Tseng, David K. Gifford Frontiers in Immunology, 2023 https://doi.org/10.3389/fimmu.2023.1135815 Additional source code is available at: https://github.com/gifford-lab/MIT-T-COVID-vaccine Please cite the paper if you use these data.

Files

Categories

Immunology, Vaccine, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19

Licence